Cardiol Therapeutics Inc. Is Maintained at Buy by Canaccord Genuity

Cardiol Therapeutics Inc. Is Maintained at Buy by Canaccord Genuity

Dow JonesMay 23 11:48 ET

Cardiol Therapeutics Says Phase II ARCHER Trial Presented at World Congress on Acute Heart Failure

Cardiol Therapeutics (CRDLTO) working on treatments for heart disease, on Tuesday said its Phase II trial evaluating the impact of CardiolRx on myocardial recovery in patients with acute myocarditis (

MT NewswiresMay 14 11:30 ET

Cardiol Therapeutics Surpasses 85% Enrollment in ARCHER Trial for Acute Myocarditis | TSX:CRDL, NASDAQ:CRDL

Proactive InvestorsMay 14 05:37 ET

Cardiol Therapeutics Inc. Initiated at Buy by H C Wainwright

Cardiol Therapeutics Inc. Initiated at Buy by H C Wainwright

Dow JonesApr 22 13:29 ET

Cardiol Therapeutics Surpasses Enrollment Goals, Prepares for Topline Results | TSX:CRDL, NASDAQ:CRDL

Proactive InvestorsApr 2 05:34 ET

Cardiol Therapeutics Completes Patient Enrollment in Its Phase II MAvERIC-Pilot Study Investigating CardiolRx(TM) for Recurrent Pericarditis

Topline Results Expected in Q2 2024This is a Designated News Release.Toronto, Ontario--(Newsfile Corp. - February 21, 2024) - Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol" or the "Co

newsfileFeb 21 07:27 ET